In a staphylococcal infection setting, riboflavin has demonstrated its anti-inflammatory property through reductions in NF-B, COX2 (cyclooxygenase 2), TNF-, NO, IL-1 (interleukin 1 beta) reducing iNOS (inducible NO synthase) synthesis, as well as an elevation in anti-inflammatory cytokine IL-10 (interleukin 10), and modulation of MCP-1 (monocyte chemoattractant protein 1) function, a potent chemoattractant (34)
Zaffagnini, M., Michelet, L., Massot, V., Trost, P
Multi-dose vial considerations require additional attention to storage and handling practices to maintain sterility throughout the use period
Our team will walk you through: what to expect, how it works, whether it fits your goals, and what a safe, medically guided protocol looks like
The peptide works best as part of a comprehensive approach addressing all aspects of recovery